Melanoma Clinical Trials

Showing 1081-1100 of 1,292 trials

Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma

NCT00978913

The primary aim of this study is to evaluate the toxicity of the vaccine and the combination of the vaccine and Cyclophosphamide, and to evaluate the immune response induced by the vaccine. The secondary aim is to investigate the clinical tumour response and duration of tumour and immune response.

Breast CancerMalignant Melanoma

Inge Marie Svane31 participantsStarted Sep 2009

Herlev, Denmark

UNKNOWN

Application of Genomic Techniques and Image Processing Using Artificial Intelligence to Obtain a Predictor Model Risk of Melanoma

NCT02511119

The aim of this study is to develop a predictive model of risk of developing melanoma. The investigators will used artificial intelligence techniques to analysed images patterns obtained by clinical and dermoscopic pictures. The investigators want to defined a new predictive risk model obtained from genetic information and image analysis of pigmented lesions. This model could help to discriminate more accurately those patients who are most likely to develop melanoma in a high-risk population.

Melanoma

Maimónides Biomedical Research Institute of Córdoba300 participantsStarted Jul 2015

COMPLETEDPhase 2

Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

NCT00563290

This phase II trial is studying how well dasatinib works in treating patients with unresectable or metastatic squamous cell skin cancer or RAI Stage 0-I chronic lymphocytic leukemia. Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Recurrent Skin CancerSquamous Cell Carcinoma of the SkinStage 0 Chronic Lymphocytic Leukemia+1 more

National Cancer Institute (NCI)7 participantsStarted Nov 2007

Cincinnati, Ohio, United States • Columbus, Ohio, United States • Houston, Texas, United States

Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma

Application of Genomic Techniques and Image Processing Using Artificial Intelligence to Obtain a Predictor Model Risk of Melanoma

Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

Related Searches

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

CCI-779 in Treating Patients With Metastatic Melanoma

Cancer Mortality Affected by the Choice of Anesthetic Drugs?

Intratumoral Administration of L19IL2/L19TNF

Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma

A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma

Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma

Comparison Of Video-based Versus Written Patient Education on Sunscreen

Study to Determine if Tissue Scored With a Scalpel Results in Any Noticeable Marks

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma